HI Fundamental Analysis - HEALTH ITALIA SPA

Fundamental Rating

HI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 26 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making HI a very profitable company, without any liquidiy or solvency issues. HI is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HI was profitable.

In the past year HI had a positive cash flow from operations.

In the past 5 years HI has always been profitable.

Each year in the past 5 years HI had a positive operating cash flow.

1.2 Ratios

With a decent Return On Assets value of 4.16%, HI is doing good in the industry, outperforming 76.92% of the companies in the same industry.

HI's Return On Equity of 6.91% is in line compared to the rest of the industry. HI outperforms 53.85% of its industry peers.

HI has a Return On Invested Capital of 5.21%. This is in the better half of the industry: HI outperforms 61.54% of its industry peers.

The Average Return On Invested Capital over the past 3 years for HI is in line with the industry average of 5.58%.

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROIC	5.21%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

1.3 Margins

Looking at the Profit Margin, with a value of 7.52%, HI belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.

In the last couple of years the Profit Margin of HI has grown nicely.

With an excellent Operating Margin value of 12.85%, HI belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.

In the last couple of years the Operating Margin of HI has grown nicely.

HI has a Gross Margin (33.27%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of HI has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	12.85%
PM (TTM)	7.52%
GM	33.27%

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

HI has more shares outstanding than it did 1 year ago.

HI has less shares outstanding than it did 5 years ago.

HI has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 3.03 indicates that HI is not in any danger for bankruptcy at the moment.

HI has a Altman-Z score of 3.03. This is amongst the best in the industry. HI outperforms 92.31% of its industry peers.

The Debt to FCF ratio of HI is 15.21, which is on the high side as it means it would take HI, 15.21 years of fcf income to pay off all of its debts.

With a Debt to FCF ratio value of 15.21, HI is not doing good in the industry: 73.08% of the companies in the same industry are doing better.

A Debt/Equity ratio of 0.22 indicates that HI is not too dependend on debt financing.

HI has a better Debt to Equity ratio (0.22) than 92.31% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Altman-Z	3.03

ROIC/WACC0.71

WACC7.34%

2.3 Liquidity

A Current Ratio of 3.18 indicates that HI has no problem at all paying its short term obligations.

HI's Current ratio of 3.18 is amongst the best of the industry. HI outperforms 96.15% of its industry peers.

HI has a Quick Ratio of 3.18. This indicates that HI is financially healthy and has no problem in meeting its short term obligations.

Looking at the Quick ratio, with a value of 3.18, HI belongs to the top of the industry, outperforming 96.15% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.18
Quick Ratio	3.18

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.15% over the past year.

HI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 181.50% yearly.

The Revenue has decreased by -0.86% in the past year.

The Revenue has been growing slightly by 2.37% on average over the past years.

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.19, the valuation of HI can be described as rather expensive.

HI's Price/Earnings ratio is in line with the industry average.

HI is valuated rather cheaply when we compare the Price/Earnings ratio to 26.73, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	20.19
Fwd PE	N/A

4.2 Price Multiples

HI's Enterprise Value to EBITDA is on the same level as the industry average.

Based on the Price/Free Cash Flow ratio, HI is valued expensively inside the industry as 88.46% of the companies are valued cheaper.

		Industry Rank	Sector Rank
P/FCF	89.39
EV/EBITDA	9.94

4.3 Compensation for Growth

The decent profitability rating of HI may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)0.11

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HI does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEALTH ITALIA SPA

BIT:HI (8/11/2025, 7:00:00 PM)

283

+3 (+1.07%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap53.77M

Analysts84.44

Price Target372.3 (31.55%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-15.12%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	20.19
Fwd PE	N/A
P/S	1.52
P/FCF	89.39
P/OCF	17.56
P/B	1.4
P/tB	1.53
EV/EBITDA	9.94

EPS(TTM)14.02

EY4.95%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)3.17

FCFY1.12%

OCF(TTM)16.11

OCFY5.69%

SpS186.12

BVpS202.44

TBVpS184.42

PEG (NY)N/A

PEG (5Y)0.11

Profitability

		Industry Rank	Sector Rank
ROA	4.16%
ROE	6.91%
ROCE	9.35%
ROIC	5.21%
ROICexc	5.54%
ROICexgc	5.97%
OM	12.85%
PM (TTM)	7.52%
GM	33.27%
FCFM	1.7%

ROA(3y)3.96%

ROA(5y)3.25%

ROE(3y)7.81%

ROE(5y)6.83%

ROIC(3y)7.13%

ROIC(5y)6%

ROICexc(3y)7.88%

ROICexc(5y)6.76%

ROICexgc(3y)8.74%

ROICexgc(5y)7.6%

ROCE(3y)12.74%

ROCE(5y)10.6%

ROICexcg growth 3Y-3.65%

ROICexcg growth 5YN/A

ROICexc growth 3Y-1.37%

ROICexc growth 5YN/A

OM growth 3Y8%

OM growth 5YN/A

PM growth 3Y33.22%

PM growth 5Y9.47%

GM growth 3Y-1.7%

GM growth 5Y-0.8%

F-Score7

Asset Turnover0.55

Health

		Industry Rank	Sector Rank
Debt/Equity	0.22
Debt/FCF	15.21
Debt/EBITDA	1.49
Cap/Depr	221.98%
Cap/Sales	6.96%
Interest Coverage	250
Cash Conversion	54.18%
Profit Quality	22.63%
Current Ratio	3.18
Quick Ratio	3.18
Altman-Z	3.03

F-Score7

WACC7.34%

ROIC/WACC0.71

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)61.15%

EPS 3Y27.76%

EPS 5Y181.5%

EPS Q2Q%504.86%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.86%

Revenue growth 3Y-3.68%

Revenue growth 5Y2.37%

Sales Q2Q%-10.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-17.66%

EBIT growth 3Y4.03%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-71.81%

FCF growth 3YN/A

FCF growth 5Y-21.09%

OCF growth 1Y43.49%

OCF growth 3Y55.79%

OCF growth 5Y-20.58%

HEALTH ITALIA SPA (HI.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens